HQY insider plans sale of 12,496 shares

A holder of common stock of the issuer has filed a notice of proposed sale covering 12,496 shares, to be sold through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 01/12/2026.

Rhea-AI Filing Summary

A holder of common stock of the issuer has filed a notice of proposed sale covering 12,496 shares, to be sold through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 01/12/2026. The filing lists an aggregate market value of 1122483.19 for these shares and notes that 85,436,286 shares of the same class are outstanding.

The shares to be sold were acquired as restricted stock vesting on 01/06/2025 directly from the issuer as compensation, in an amount matching the proposed sale of 12,496 shares. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HQY issuer shares are proposed for sale in this Form 144?

The notice covers the proposed sale of 12,496 shares of the issuer's common stock.

What is the aggregate market value of the HQY shares to be sold?

The filing reports an aggregate market value of 1122483.19 for the 12,496 common shares to be sold.

When were the HQY shares being sold acquired by the insider?

The shares were acquired on 01/06/2025 through restricted stock vesting from the issuer as compensation.

On which exchange and through which broker will the HQY shares be sold?

The notice states the common stock will be sold on the NASDAQ through Morgan Stanley Smith Barney at its Purchase, NY office.

How many shares of this class are outstanding for the HQY issuer?

The filing lists 85,436,286 shares of common stock outstanding for this class.

What assurance does the seller give about nonpublic information in this HQY Form 144?

By signing, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/14/2026 - 04:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715537
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHEQUITY, INC.
SEC File Number	001-36568
Address of Issuer	15 WEST SCENIC POINTE DRIVE SUITE 100 DRAPER UTAH 84020
Phone	801.727.1000
Name of Person for Whose Account the Securities are To Be Sold	Scott Cutler
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney 2000 Westchester Ave Purchase NY 10577-2530	12496	1122483.19	85436286	01/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/06/2025	Restricted Stock Vesting	ISSUER			12496	01/12/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Date of Notice	01/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Newton, Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)